Listen to POA Chairman Dr. Chadi Nabhan address members of the POA as he highlights all of the content in this anniversary issue of the Caris Connection e-newsletter.
Vall d´Hebron Institute of Oncology (VHIO) is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of our patients.
POA Chairman, Dr. Chadi Nabhan, sits down with Dr. Neeraj Agarwal, Director of the Genitourinary Oncology Program at the Huntsman Cancer Institute. Together they discuss genomic profiling and sequencing in GU malignancies.
Tune in to hear POA Chairman Dr. Chadi Nabhan interview many of today’s leading experts as they discuss the latest developments in the fields of oncology and precision medicine.
Learn more about the Vall d´Hebron Institute of Oncology (VHIO) and how this POA institution is accelerating and advancing personalized and targeted therapies against cancer.
Host: Dr. Chadi Nabhan
Guest: Dr. Neeraj Agarwal
Senior Director for Clinical Research Innovation – Huntsman Cancer Institute (HCI).
Tune in to hear POA Chairman Dr. Chadi Nabhan interview many of today’s leading oncology experts as they discuss the latest developments and breakthroughs in the fields of oncology and precision medicine.
Caris Life Sciences® scientists and collaborators from the Precision Oncology Alliance™ (POA) presented new findings to advance cancer care and guide treatment decisions at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting, June 4 to 8, 2021.
CASE STUDY: Caris GPSai™. A 50-year-old female patient was originally diagnosed with ovarian endometrioid adenocarcinoma. Through Caris GPSai it was determined the primary cancer was metastatic colonic adenocarcinoma.
Contact Caris Precision Oncology Alliance
If you would like additional information on the POA, have questions, comments, or ideas, we’d love to hear from you. Please click on the link below.